The basic principle of the company's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases [REF].
In 2006, CureVac successfully established the first GMP facility worldwide for the manufacturing of mRNA for medical purposes [REF].